We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Biomedical Research Consortium for Regenerative Medicine Under Construction

By LabMedica International staff writers
Posted on 04 May 2010
A new US$126 million, 13,536-m2 biomedical research "collaboratory” will pursue joint projects by its members and collaboration partners to invent tools and technologies intended to advance research into stem cells, and to discover and develop innovative diagnostics and therapies. More...


The Sanford Consortium for Regenerative Medicine, a consortium of four world leaders in life sciences research (the Salk Institute for Biological Studies, The Scripps Research Institute (La Jolla, CA, USA), Sanford-Burnham Medical Research Institute (La Jolla), and the University of California, San Diego, hosted an official groundbreaking ceremony on March 26, 2010, in La Jolla, CA, USA.

The consortium, formed in 2006 to build and operate the biomedical research laboratory, consists of these four leading medical institutions--all internationally known for their exceptional contributions to medical research and treatments.

The Sanford Consortium for Regenerative Medicine will be a preeminent research center to develop the next generation of breakthrough cures, therapies, diagnostics, research tools, and technologies in stem cell research. The consortium's key research focuses on stem cell growth and differentiation, neuroscience, cardiovascular biology, blood cell development, and vision science.

The Sanford Consortium for Regenerative Medicine is designed as one of the most forward-thinking laboratories, effectively fostering informal collaboration and communication among researchers in a synergistic environment. Shared two-story break rooms interconnect all levels and encourage interaction among researchers. Approximately 330 investigators and associated staff will occupy the open labs, offices, and specialized core labs. Conference facilities include a 150-seat auditorium, large divisible conference room and a café.

Related Links:
Sanford Consortium for Regenerative Medicine


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Chromogenic Culture System
InTray™ COLOREX™ ECC
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.